Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD

NCT02576626 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: indacaterol/glycopyrronium 110/50 Breezhaler®
DEVICE: Placebo by Breezhaler®
DRUG: ipratropium/salbutamol 0,5 mg, 2,5 mg by nebulisation
DEVICE: Placebo by nebulisation

Sponsor

Wouter H. van Geffen

Collaborators

[object Object]
[object Object]